Zobrazeno 1 - 10
of 109
pro vyhledávání: '"Mariana C. Duarte"'
Autor:
Tauane G. Soyer, Fernanda F. Ramos, Isabela A. G. Pereira, Daniela P. Lage, Raquel S. Bandeira, Marcelo M. de Jesus, Guilherme P. Costa, Amanda S. Machado, Camila S. Freitas, Danniele L. Vale, Vívian T. Martins, Alexsandro S. Galdino, Miguel A. Chávez-Fumagalli, Daniel Menezes-Souza, Mariana C. Duarte, Bruno M. Roatt, Eduardo A. F. Coelho, Grasiele S. V. Tavares
Publikováno v:
Pathogens, Vol 12, Iss 2, p 314 (2023)
Leishmania amazonensis can cause cutaneous and visceral clinical manifestations of leishmaniasis in infected hosts. Once the treatment against disease is toxic, presents high cost, and/or there is the emergence of parasite-resistant strains, alternat
Externí odkaz:
https://doaj.org/article/0e72ffa459d24221bdbdd07350467a1d
Autor:
Débora V.C. Mendonça, Grasiele S.V. Tavares, Daniela P. Lage, Tauane G. Soyer, Lívia M. Carvalho, Daniel S. Dias, Patrícia A.F. Ribeiro, Flaviano M. Ottoni, Luciana M.R. Antinarelli, Danniele L. Vale, Fernanda Ludolf, Mariana C. Duarte, Elaine S. Coimbra, Miguel A. Chávez-Fumagalli, Bruno M. Roatt, Daniel Menezes-Souza, José Mário Barichello, Ricardo J. Alves, Eduardo A.F. Coelho
Publikováno v:
Biomedicine & Pharmacotherapy, Vol 109, Iss , Pp 779-787 (2019)
New therapeutic strategies against leishmaniasis are desirable, since the treatment against disease presents problems, such as the toxicity, high cost and/or parasite resistance. As consequence, new antileishmanial compounds are necessary to be ident
Externí odkaz:
https://doaj.org/article/e7491b6934e34937acd1c17a6771ef90
Autor:
Vivian T. Martins, Mariana C. Duarte, Miguel A. Chávez-Fumagalli, Daniel Menezes-Souza, Cecília S. P. Coelho, Danielle F. de Magalhães-Soares, Ana Paula Fernandes, Manuel Soto, Carlos A. P. Tavares, Eduardo A. F. Coelho
Publikováno v:
Parasites & Vectors, Vol 8, Iss 1, Pp 1-12 (2015)
Abstract Background LiHyV is an antigenic hypothetical protein present in both promastigote and amastigote stages of Leishmania infantum, which was recently identified by an immunoproteomic approach. A recombinant version of this protein (rLiHyV) was
Externí odkaz:
https://doaj.org/article/a7fdaa5f4dee4d9fab415554a1b05082
Autor:
Daniela P. Lage, Amanda S. Machado, Camila S. Freitas, Danniele L. Vale, Flávia P. Linhares, Jamille M.O. Cardoso, João A. Oliveira-da-Silva, Fernanda F. Ramos, Isabela A.G. Pereira, Fernanda Ludolf, Grasiele S.V. Tavares, Raquel S. Bandeira, Jamil S. Oliveira, Daniel Menezes-Souza, Mariana C. Duarte, Alexsandro S. Galdino, Myron Christodoulides, Miguel A. Chávez-Fumagalli, Bruno M. Roatt, Vívian T. Martins, Eduardo A.F. Coelho
Publikováno v:
Molecular Immunology. 155:79-90
Autor:
null Amanda S. Machado, null Daniela P. Lage, null Danniele L. Vale, null Camila S. Freitas, null Flávia P. Linhares, null Jamille M. O. Cardoso, null João A. Oliveira‐da‐Silva, null Isabela A. G. Pereira, null Fernanda F. Ramos, null Grasiele S. V. Tavares, null Fernanda Ludolf, null Raquel S. Bandeira, null Luiz G. N. Maia, null Daniel Menezes‐Souza, null Mariana C. Duarte, null Miguel A. Chávez‐Fumagalli, null Bruno M. Roatt, null Myron Christodoulides, null Vívian T. Martins, null Eduardo A. F. Coelho
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::2320d5fa9e6ce63de7f41a4a8f63b1e4
https://doi.org/10.1111/pim.12921/v2/response1
https://doi.org/10.1111/pim.12921/v2/response1
Autor:
Amanda S. Machado, Daniela P. Lage, Danniele L. Vale, Camila S. Freitas, Flávia P. Linhares, Jamille M. O. Cardoso, João A. Oliveira‐da‐Silva, Isabela A. G. Pereira, Fernanda F. Ramos, Grasiele S. V. Tavares, Fernanda Ludolf, Raquel S. Bandeira, Luiz G. N. Maia, Daniel Menezes‐Souza, Mariana C. Duarte, Miguel A. Chávez‐Fumagalli, Bruno M. Roatt, Myron Christodoulides, Vívian T. Martins, Eduardo Antonio Ferraz Coelho
Publikováno v:
Parasite immunologyREFERENCES. 44(8)
Treatment against visceral leishmaniasis (VL) presents problems by the toxicity of drugs, high cost and/or emergence of resistant strains. The diagnosis is hampered by variable sensitivity and/or specificity of tests. In this context, prophylactic va
Autor:
Débora V.C. Mendonça, Grasiele S.V. Tavares, Isabela A.G. Pereira, João A. Oliveira-da-Silva, Fernanda F. Ramos, Daniela P. Lage, Amanda S. Machado, Lívia M. Carvalho, Thiago A.R. Reis, Ana Maria R.S. Carvalho, Flaviano M. Ottoni, Fernanda Ludolf, Camila S. Freitas, Vívian T. Martins, Miguel A. Chávez-Fumagalli, Mariana C. Duarte, Maria V. Humbert, Bruno M. Roatt, Daniel Menezes-Souza, Ricardo J. Alves, Eduardo A.F. Coelho
Visceral leishmaniasis (VL) is a neglected tropical disease found in tropical and subtropical regions in the world. The therapeutics used for the treatment against disease presents problems, mainly related to drug toxicity, route of administration, h
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7077fc6be3140cdb5be61c3f1d595aeb
https://eprints.soton.ac.uk/456041/
https://eprints.soton.ac.uk/456041/
Autor:
Luciana M. Ribeiro Antinarelli, Nícolas Glanzmann, Débora V. C. Mendonça, Daniela P. Lage, João A. Oliveira-da-Silva, Grasiele S. V. Tavares, Ana Maria R. S. Carvalho, Camila S. Freitas, Vívian T. Martins, Mariana C. Duarte, Daniel Menezes-Souza, Adilson David da Silva, Eduardo Antônio Ferraz Coelho, Elaine Soares Coimbra
Publikováno v:
Parasitology research. 121(7)
Leishmaniasis is a parasitic disease caused by Leishmania protozoa, which presents a large spectrum of clinical manifestations. In the present study, a quinoline derivative salt named N-(2-((7-chloroquinolin-4-yl)amino)ethyl)-N-(prop-2-yn-1-yl)prop-2
Autor:
Amanda S. Machado, Daniela P. Lage, Danniele L. Vale, Camila S. Freitas, Flávia P. Linhares, Jamille M.O. Cardoso, Isabela A.G. Pereira, Fernanda F. Ramos, Grasiele S.V. Tavares, Fernanda Ludolf, João A. Oliveira-da-Silva, Raquel S. Bandeira, Aratti C. Simões, Mariana C. Duarte, Jamil S. Oliveira, Myron Christodoulides, Miguel A. Chávez-Fumagalli, Bruno M. Roatt, Vívian T. Martins, Eduardo A.F. Coelho
Publikováno v:
Acta tropica. 230
Vaccination against visceral leishmaniasis (VL) should be considered as a control measure to protect against disease, and amastigote-specific proteins could help to develop such vaccines, since this parasite form is in contact with the host immune sy
Autor:
Lourena E. Costa, Danniele L. Vale, Eduardo A.F. Coelho, Patricia Silveira, Denise Utsch Gonçalves, Patrícia A.F. Ribeiro, Ana Thereza Chaves, Amanda S. Machado, Daniela P. Lage, Daniel Dias, Grasiele S.V. Tavares, Fernanda Ludolf, Vívian T. Martins, Fernanda F. Ramos, Rachel B. Caligiorne, Manoel Otávio da Costa Rocha, Miguel A. Chávez-Fumagalli, Mariana C. Duarte
Publikováno v:
Parasitology. 146:1467-1476
There is no suitable vaccine against human visceral leishmaniasis (VL) and available drugs are toxic and/or present high cost. In this context, diagnostic tools should be improved for clinical management and epidemiological evaluation of disease. How